Uncertainty in Europe, Asia drive down Hurco profit
Indianapolis-based Hurco, a maker of computer-controlled machining tools, earned less than $4 million during the quarter ended July 31, down 13.5 percent from the same quarter a year ago.
J.K. Wall
Articles
Eli Lilly aims to ramp up social media presence
The drugmaker recently drafted social media guidelines it hopes can help it expand its use of social media to more of its employees—without running afoul of regulators.
St. Vincent adds Bloomington hospital to its fold
Indianapolis-based St. Vincent Health will manage operations at Monroe Hospital in Bloomington under an agreement announced on Tuesday. Monroe gives St. Vincent a line of hospitals stretching from Indianapolis to Bedford and even farther south to Salem and Evansville.
Bounty on Braly? $1.4 billion
Investors who called strongly for the head of WellPoint Inc. CEO Angela Braly got what they wanted last week. In response, they bid up WellPoint's share price by $1.4 billion on the day after she resigned.
Two more clinical trials go against Lilly
In the midst of Eli Lilly and Co.’s surprisingly positive news about its experimental Alzheimer’s drug, the company suffered two other setbacks with former stars of its pipeline.
Lumina betting $10M on startups
Indianapolis-based Lumina Foundation, one of the nation’s largest donors to education groups, has given $10 million to a venture capital firm to fund for-profit startups with ideas to meet the nation’s education challenges.
Education veteran predicts decade of drastic change
New laws, new technology and a new era of flat funding will bring more change to Indiana’s public schools in the next decade than occurred in the past century, predicts David Dresslar, a former school superintendent who is now executive director of the Center of Excellence in Leadership of Learning at the University of Indianapolis.
Departing CEO Braly due to get $15M exit package
WellPoint Inc. is expected to give about $15 million in cash, stock and benefits to former CEO Angela Braly on her way out the door, based on the terms of a separation agreement filed by the company Wednesday morning. And the payout could be even more lucrative based on the company’s future stock price.
Does Lilly have enough on Alzheimer’s drug?
After Eli Lilly and Co. found a “glimmer of hope” in its test of its experimental Alzheimer’s drug, doctors and stock analysts generally concluded the company needs to conduct another long clinical trial to prove the drug’s effect. But one stock analyst thinks Lilly already has what it needs to ask for approval for its drug.
Subsidies might hang in the balance of state’s exchange decision
There’s more than political philosophy at stake as Indiana’s candidates for governor wrestle over whether the state should start its own health insurance exchange. There’s potentially a lot of money for low- and moderate-income Hoosiers at stake, too.
Alzheimer’s drug results leave Lilly ‘excited’ but uncertain
The surprise positive effect shown by an experimental Alzheimer’s drug “excited” executives at Eli Lilly and Co., but it raised as many questions as it answered.
Lilly’s Alzheimer’s drug trials show mixed results
Eli Lilly and Co.’s experimental Alzheimer’s drug failed to meet its primary goals in two separate clinical trials. However, when the results of both trials were combined, the drug appeared to have slowed the decline of cognition in some patients.
Cutting bills fuels growth of Health Systems International
Health Systems is on pace this year for nearly $50 million in revenue, up from $42 million last year and just $4.5 million eight years ago. The Indianapolis company processes claims for health insurers when patients receive out-of-network care.
Rival’s strong results have WellPoint playing catch-up
UnitedHealth has been enjoying healthy profits, growing customer rolls and a rising stock price—things the Indianapolis insurer has been unable to match. That tough comparison lies behind some of the investor attacks on WellPoint CEO Angela Braly.
GOP govs: Not enough Medicaid ‘flexibility’
The Obama administration is giving states like Indiana a little flexibility in how to expand their Medicaid programs—but nothing like what state officials hoped for after the U.S. Supreme Court struck down part of the law in late June.
WellPoint dragged into Goldman Sachs suit
WellPoint Inc.’s $4.9 billion offer for Virginia-based Amerigroup Inc. apparently wasn’t the only—or even the most lucrative—offer for the Medicaid managed care company. But it was the deal surest to come to fruition before a key deadline for a big payout for Goldman Sachs & Co., according to a shareholder lawsuit filed Aug. 16 against the Amerigroup board of directors.
Old National to close nine branches in Indianapolis area
Evansville-based Old National Bank will close nine Indianapolis-area branches near the end of the year and consolidate them into nearby branches in a move to streamline its operations.
Life sciences firm Hologic closing 200-worker Zionsville facility
Massachusetts-based Hologic Inc., the company that bought Suros Surgical Systems Inc., will phase out its facility in Zionsville, bringing an end to 200 local jobs.
State schools chief’s mentor taught him to ruffle feathers to improve education
Superintendent of Public Instruction Tony Bennett credits retired education professor John Moody with inspiring much of the reform agenda he has pushed over the past four years.
Hoops success helps Butler avoid enrollment decline
Butler University has seen applications spike 43 percent over the last two years even though its 2009 strategic plan warned against a coming enrollment decline. The big difference? March Madness.